1. Albiglutide: clinical overview of a long-acting GLP-1 receptor agonist in the treatment of Type 2 diabetes. Issue 3 (May 2013) Authors: Setji, Tracy; Feinglos, Mark Journal: Expert review of endocrinology & metabolism Issue: Volume 8:Issue 3(2013) Page Start: 229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Munakataite, Pb2Cu2(Se4+O3)(SO4)(OH)4, and Other Selenium Minerals from Tsumeb, Namibia. Issue 6 (1st November 2016) Authors: Flynn, Shields; Barton, Isabel F.; Feinglos, Mark Journal: Rocks and minerals Issue: Volume 91:Issue 6(2016) Page Start: 548 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Non-invasive wearables for remote monitoring of HbA1c and glucose variability: proof of concept. Issue 1 (15th June 2021) Authors: Bent, Brinnae; Cho, Peter J; Wittmann, April; Thacker, Connie; Muppidi, Srikanth; Snyder, Michael; Crowley, Matthew J; Feinglos, Mark; Dunn, Jessilyn P Journal: BMJ open diabetes research and care Issue: Volume 9:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Time of Day When Type 1 Diabetes Patients With Eating Disorder Symptoms Most Commonly Restrict Insulin. Issue 2 (February 2018) Authors: Merwin, Rhonda M.; Moskovich, Ashley A.; Honeycutt, Lisa K.; Lane, James D.; Feinglos, Mark; Surwit, Richard S.; Zucker, Nancy L.; Dmitrieva, Natalia O.; Babyak, Michael A.; Batchelder, Heather; Mooney, Jan Journal: Psychosomatic medicine Issue: Volume 80:Issue 2(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗